Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Lok™ suture anchors: safety and performance

Official title: Evaluation of the Safety and Performance of the Lok™ Suture Anchors Range and Associated Instrumentation - Multicenter Interventional and Single Blind Randomized Clinical Trial

Run by Move Up SAS · NCT07448584 · Data updated 2026-11-12

This will test whether Move‑Up's lok™ suture anchors are safe and help adults with rotator cuff or labrum injuries who need shoulder repair surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment216 (estimated)
SponsorMove Up SAS
Industry-sponsored
Locations1 site (Valence, Auvergne-Rhône-Alpes)
StatusRecruiting
StartedMarch 5, 2026
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedApril 15, 2026
Trial IDNCT07448584 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with MRI or arthrogram-confirmed rotator cuff lesions with biceps pathology, glenohumeral instability, or PASTA lesions who are scheduled for surgical repair and can consent are ideal candidates.

Probably not a fit

Patients with shoulder fractures, major trauma, active infection, avascular necrosis, severe degenerative arthropathy, significant bone loss or other conditions that impair suture fixation are unlikely to benefit or meet inclusion criteria.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with rotator cuff tears, labrum injuries or PASTA lesions who undergo surgical repair with the lok™ suture anchors will be followed after surgery. Clinical outcomes will be measured at about 3, 6 and 12 months using the Constant score, VAS pain score, and Subjective Shoulder Value. Tendon healing and recurrence of rupture will be evaluated at 6 and 12 months using the Sugaya score on ultrasound, and adverse events will be recorded at 1, 3, 6 and 12 months. The trial is conducted at a single participating center and includes predefined inclusion and exclusion criteria to select appropriate surgical candidates.

Why it matters

Potential benefit: If successful, the lok™ anchors could offer a safe option that improves tendon healing and reduces repair failures after shoulder surgery.

How similar studies have gone: Other suture‑anchor systems are widely used and prior studies generally show acceptable safety and repair outcomes, but published data specific to the lok™ system are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Consent to participate in the study: oral and written.
* Man or woman over 18 years old with bone maturity finished.
* Presented with one of the following indications:

  * Rotator cuff lesion (tear or calcific tendinopathy) associated to a pathology of the long head of the biceps,
  * Gleno-humeral instability,
  * partial articular-sided tendon avulsion \[PASTA\] lesion.
* MRI or arthrogram proving the rotator cuff lesion and long head of the biceps tendon injury, or the labrum injury, or PASTA injury.

Non inclusion Criteria:

* Radiographic sign of fracture: glenoid or lesser tuberosity.
* Major trauma to the shoulder joint.
* Any active infection or avascular necrosis.
* Inflammatory joint disease.
* Moderate to severe degenerative glenohumeral arthropathy (Kellgren-Lawrence Grade 3 or 4).
* Bone pathologies compromising anchorage (cystic changes, severe osteopenia).
* Pathological conditions of soft tissues impairing suture fixation.
* Known hypersensitivity to implant material (PEEK and carbon or Polyethylene).
* Anterior ipsilateral surgeries performed on the joint space.
* Physical conditions that would eliminate, or tend to eliminate, adequate anchoring support or delay healing.
* Contraindications from the instructions for use of the medical devices used.
* Conditions that would limit the subject's ability or willingness to restrict activities or follow instructions during the healing period.
* Inability to complete questionnaires: language problems, who do not speak/read/understand French.
* Pregnant or breastfeeding women.
* Persons deprived of liberty or under guardianship.
* Patients unable to undergo medical monitoring of the trial.
* Psychiatric illnesses, cognitive disorders, or health problems that prevent informed consent.
* Participation in another clinical trial.
* Life expectancy of less than 12 months.
* No health insurance.

Where it's running

  • Alixan
    Valence, Auvergne-Rhône-Alpes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.